SCHEMBL18172231

SCHEMBL18172231

Nc1c(C(=O)Nc2ccc(C(F)(F)F)cn2)cnn1-c1ccccc1-c1cccnc1

nearest known ligand 0.75

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
SCN9A Q15858 9/20 0.75
SCN5A Q14524 2/20 0.75
DYRK1A Q13627 1/20 0.52
EPHX2 P34913 2/20 0.47
TRPV1 Q8NER1 1/20 0.46
PTGS1 P23219 1/20 0.46
MAPT P10636 1/20 0.42
GSK3A P49840 1/20 0.42
GSK3B P49841 1/20 0.42
ABCB1 P08183 1/20 0.42
ABCC1 P33527 1/20 0.42
HCRTR1 O43613 1/20 0.42
F10 P00742 1/20 0.42
GAA P10253 1/20 0.42
PTGES O14684 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18172119 0.84 SCN9A (1.00) SCN9ASCN5ATRPV1PTGS1F10
SCHEMBL18172166 0.83 SCN9A (0.73) SCN9ASCN5ADYRK1AEPHX2TRPV1
SCHEMBL18172107 0.83 SCN9A (0.80) SCN9ASCN5ATRPV1PTGS1HCRTR1
SCHEMBL18172171 0.82 SCN9A (0.78) SCN9ASCN5ATRPV1PTGS1MAPT
SCHEMBL18172191 0.80 SCN9A (0.75) SCN9ASCN5ATRPV1PTGS1MAPT
SCHEMBL18172037 0.80 SCN9A (0.75) SCN9ASCN5ATRPV1PTGS1MAPT
SCHEMBL18172214 0.80 SCN9A (0.66) SCN9ASCN5APTGS1MAPTHCRTR1
SCHEMBL18172174 0.79 SCN9A (0.75) SCN9ASCN5APTGS1MAPTHCRTR1
SCHEMBL18172216 0.79 SCN9A (0.72) SCN9ASCN5APTGS1MAPTGAA
SCHEMBL18172018 0.78 SCN9A (0.72) SCN9ASCN5APTGS1MAPTF10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3286178-A1 AMINO-SUBSTITUTED HETEROCYCLIC DERIVATIVES AS SODIUM CHANNEL INHIBITORS Almirall S.A. (ES) 2018-02-28 EP disclosed
WO-2016170009-A1 AMINO-SUBSTITUTED HETEROCYCLIC DERIVATIVES AS SODIUM CHANNEL INHIBITORS ALMIRALL, S.A. (ES) 2016-10-27 WO disclosed